A possible mechanism concerning the resistance is that the exosomal PD-L1 is highly expressed and competitively binds to anti-PD-L1 antibodies, causing PD-L1 on the surface of tumor cells to be able to bind to the PD-1 receptor of T cells and inhibit T cell function. Here, CD274 is linked to neoplasm.